Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1492 |
---|---|
Product Name | Anti-Human ANGPT2 & VEGFA Recombinant Antibody(Faricimab) |
Molecular Name | Faricimab |
Alias | Anti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Faricimab |
CAS Number | 1607793-29-2 |
Target | ANGPT2 & VEGFA[Homo sapiens] |
Isotype | IgG1 Kappa Lambda |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Buffer | PBS, pH7.5 |
Background | Faricimab (INN) is a bispecific monoclonal antibody that is being investigated for diabetic macular edema. This drug is being developed by Hoffmann-La Roche. As of 2018, faricimab is undergoing Phase III trials. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |